RichardScartozziMD, FACS, FICS, FAAO, FAPCR, CPI

Ophthalmology • Danbury, CT

Retinal Disease

Dr. Richard Scartozzi, MD, FACS, FICS, FAAO, FAPCR, CPI, specializes in diseases and surgery of the retina, macula, and vitreous as a Vitreoretinal Surgeon, Partner, and Principal Investigator at Connecticut Eye Consultants

Join to view full profile

Dr. Scartozzi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Scartozzi's full profile

Already have an account?

Office
69 Sand Pit Road
Danbury, CT 06810
Phone+1 203-791-2020

Fax+1 203-778-6238
Is this information wrong?

Summary

Doctor Richard Scartozzi, MD, FACS, FICS, FAAO, FAPCR, CPI, is a clinician/surgeon, teacher, and researcher with years of experience. He has trained at top institutions such as Johns Hopkins Medical School, Wills Eye Hospital, and Doheny Eye Institute. Doctor Scartozzi is a Connecticut retina and macula specialist with a national reputation, skilled in the treatment of macular degeneration, macular holes and puckers, diabetic retinopathy, retinal detachments and tears, floaters, retinal vein occlusions, complications of cataract surgery, uveitis, sutureless small gauge vitrectomy surgery, eye laser surgery, and the use of Eylea, Vabysmo, Lucentis, Avastin, Ozurdex, Jetrea, macular eye vitamins, and other eye therapies.

Education & Training

University of Southern California/LAC+USC Medical CenterFellowship, Surgical Retina and Vitreous, 2006 - 2008
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2003 - 2006
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 2002 - 2003
Johns Hopkins University School of MedicineClass of 2002, M.D., Class Rank: 14 of 114
SUNY at Stony BrookB.S., Biochemistry, Valedictorian, 1994 - 1998

Certifications & Licensure

CA State Medical License 2006 - Present
NY State Medical License 2008 - 2026
CT State Medical License 2007 - 2025
PA State Medical License 2003 - 2006
American Board of Ophthalmology Ophthalmology
Association of Clinical Research ProfessionalsCertified Principal Investigator

Awards, Honors, & Recognition

Fellow (FAPCR) Academy of Physicians in Clinical Research, 2016
Fellow (FICS) International College of Surgeons, 2014
Certified Principal Investigator (CPI) Association of Clinical Research Professionals, 2014
Top Doctors: New York Metro Area Castle Connolly, 2014
Top Doctor Award International Association of Ophthalmologists, 2013
Top Doctor Award Castle Connolly, 2013
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Fellow (FAAO) American Academy of Ophthalmology
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Start of enrollment: 2012 Aug 01
Completed
Phase 3
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 Start of enrollment: 2014 Dec 08
Completed
Phase 3
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy Start of enrollment: 2015 Sep 24
Completed
Phase 2
CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA) Start of enrollment: 2015 Sep 25
Completed
Phase 2
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Start of enrollment: 2018 Jul 23
Completed
Phase 3
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration Start of enrollment: 2018 Aug 31
Completed
Phase 3
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) Start of enrollment: 2020 Jun 22
Completed
Phase 3
A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2020 Sep 25
Completed
Phase 3
A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) Start of enrollment: 2020 Sep 30
Terminated
Phase 3
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD) Start of enrollment: 2021 Mar 12
Active, not recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) Start of enrollment: 2021 Jun 15
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR) Start of enrollment: 2021 Aug 30
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

12 citations
Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection.
R Scartozzi, J R Chao, A. C. Walsh, Dean Eliott> ;Eye. 2009 May 1
Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Saline for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.
> ;JAMA Ophthalmol . 2013 Jan 31
Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
Gangaputra S Drye L Vaidya V Thorne JE Jabs DA Lyon AT > ;Am J Ophthalmol . 2013 Feb
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Sugar EA Jabs DA Ahuja A Thorne JE Danis RP Meinert CL > ;Am J Ophthalmol . 2012 Jun
Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.
Sezgin, E., van Natta, M. L., Ahuja, A., Lyon, A., Srivastava, S., Troyer, J. L., O'Brien, S. J., Jabs, D. A.> ;Am J Ophthalmol. 2011 Jun
4 citations
Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes.
Richard Scartozzi, D. Tom, Peter E. Liggett, Harry W. Flynn> ;Ophthalmic Surgery, Lasers & Imaging. 2011 Mar 10
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
Jabs, D. A., Ahuja, A., Van Natta, M., Lyon, A., Srivastava, S., Gangaputra, S.> ;Ophthalmology. 2010 Nov
Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.
Puhan, M. A., Van Natta, M. L., Palella, F. J., Addessi, A., Meinert, C.> ;Clin Infect Dis. 2010 Oct 15
1 citations
Rhegmatogenous retinal detachment after a lower extremity dog bite: a case report
Tarek Alasil, Sam Eljammal, Richard Scartozzi, Dean Eliott> ;Cases Journal. 2008 Oct 7
76 citations
Intraoperative Sclerotomy-related Retinal Breaks for Macular Surgery, 20- vs 25-Gauge Vitrectomy Systems
Richard Scartozzi, Amr Saad Bessa, Omesh P. Gupta, Carl D. Regillo> ;American Journal of Ophthalmology. 2007 Jan 1
646 citations
Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1.
Jerry A. Shields, Carol L. Shields, Richard Scartozzi> ;Ophthalmology. 2004 May 1
71 citations
Review: primary epithelial malignancies of the lacrimal gland: the 2003 Ramon L. Font lecture.
Jerry A. Shields, Carol L. Shields, John A. Epstein, Richard Scartozzi, Ralph C. Eagle> ;Ophthalmic Plastic and Reconstructive Surgery. 2004 Jan 1
6 citations
Chondroid Chordoma of the Nasal Septum
Richard Scartozzi, Marion E. Couch, James J. Sciubba> ;Archives of Otolaryngology--Head & Neck Surgery. 2003 Feb 1
79 citations
O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation?
Robert S. Haltiwanger, Scott Busby, Kathleen Grove, Sean Li, Doug Mason, Lillian Medina, Daniel J. Moloney, Glenn A. Philipsberg, Richard Scartozzi> ;Biochemical and Biophysical Research Communications. 1997 Feb 13
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow
American Society of Retina Specialists - ASRS
Member
International College of Surgeons - ICS
Fellow
American College of Surgeons - ACS
Fellow
New England Ophthalmological Society
Member
Academy of Physicians in Clinical Research - APCR
Fellow
Connecticut Society of Eye Physicians
Member
Vit-Buckle Society
Member

Other Languages

Italian

Hospital Affiliations

Hospital of St RaphaelNew Haven, Connecticut
St. Vincent's Medical CenterBridgeport, Connecticut
Yale-New Haven HospitalNew Haven, Connecticut
Danbury HospitalDanbury, Connecticut
New Milford HospitalNew Milford, Connecticut
Saint Mary's HospitalWaterbury, Connecticut

External Links

Practicehttp://www.cteye2020.com/
Professionalhttp://www.drscartozzi.com